|
US2021070787A1
|
|
Mito-Honokiol Compounds and Methods of Synthesis and Use Thereof
|
|
WO2021081500A1
|
|
Mitochondria-targeted atovaquone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug
|
|
US2021110886A1
|
|
Gene expression signature of hyperprogressive disease (hpd) in patients after anti-pd-1 immunotherapy
|
|
WO2021055801A1
|
|
Improved alpha-galactosidase protein for enzyme replacement therapy (ert) and methods of use
|
|
WO2021030466A1
|
|
Simultaneous multi-orientation magnetic resonance imaging
|
|
US2020360479A1
|
|
Engineered ccl20 locked dimer polypeptide
|
|
WO2021021885A1
|
|
Methods of treating advanced prostate cancer
|
|
WO2021011775A1
|
|
Systems and methods for generating classifying and quantitative analysis reports of aneurysms from medical image data
|
|
WO2020223158A1
|
|
Trans-tympanic membrane delivery platform and uses thereof
|
|
WO2020214606A1
|
|
Recombinant pd-l1 peptides and methods of use
|
|
WO2020206351A1
|
|
Systems, methods, and media for automatically determining audio gain profiles for fitting personal audio output devices
|
|
WO2020206292A2
|
|
Assessing conditions in transplant subjects using donor-specific cell-free dna
|
|
WO2020206290A1
|
|
Methods for assessing risk using total cell-free dna
|
|
WO2020206269A1
|
|
Transplant patient monitoring with cell-free dna
|
|
WO2020205842A1
|
|
Tip60 inhibitors and methods of use for cardiovascular disease
|
|
WO2020209972A2
|
|
Effects of age-dependent changes in cell size on endothelial cell growth
|
|
WO2020172314A1
|
|
Apparatus and method for teaching wound debridement
|
|
WO2020160451A1
|
|
Systems and methods for sound mapping of anatomical and physiological acoustic sources using an array of acoustic sensors
|
|
WO2020154521A1
|
|
Systems and methods for continence training
|
|
WO2020146252A1
|
|
Medical equipment support and placement block for medical procedures
|
